ExxonMobil Shuts Another Singapore Facility: The Global Petrochemical Shake-Up Leaves No Easy Winners
In late May, news broke that ExxonMobil had shut down a chemical facility in Singapore. The official explanation was restrained: market conditions were unfavorable, and the company added that the unit could restart if the market improved. But anyone in the industry knows this is not just a temporary maintenance story. It is another heavy blow in the global petrochemical capacity shake-out.
This is not the first time ExxonMobil has made such a move. From the older steam cracker on Singapore’s Jurong Island to the ethylene plant in Scotland that had operated for more than 40 years, the company has been closing, shrinking and reshuffling assets within a short period. When even an industry giant starts actively cutting capacity, it means the downturn is far colder than many expected.
It Is Not Just Old Equipment. It Is Capacity That No Longer Makes Money
Many people may blame the latest shutdown on the age of the facility, which began operations in 2002. But that is only the surface explanation. The real problem is that the economics of the current naphtha-based route have become increasingly difficult.
Steam cracking is the “throat” of the petrochemical industry. Once a cracker stops, downstream chains such as polyethylene, polypropylene and ethylene glycol all feel the shock. Singapore remains one of Asia’s most important chemical hubs, with strong ports, logistics and supporting infrastructure. But one issue is hard to avoid: feedstock cost.
North America has low-cost shale gas ethane. The Middle East has cheaper crude and energy resources. China has newly built integrated refining and petrochemical mega-complexes. Singapore’s older units are stuck in the middle. Without a clear feedstock advantage or scale dividend, they can easily become “negative assets” on a global giant’s balance sheet.
The Fife ethylene plant in Scotland tells the same story. With about 830,000 tons/year of ethylene capacity and a position as a key piece of UK chemical infrastructure, it still moved toward early retirement under the pressure of high costs, weak margins and policy burdens. That punctures one illusion: not every “strategic asset” has a permanent survival card. If cash flow cannot hold, even giants will cut.
The Global Ethylene Chain Has Moved From Expansion Race to Elimination Match
ExxonMobil’s actions are not isolated. They reflect a broader industry shift.
Over the past decade, the global petrochemical industry competed on who could expand faster and who could build deeper integration. Now, the question has changed: who has the lowest cost, who owns newer assets, and who can survive a long low-margin cycle.
China’s wave of new capacity, combined with weak end-market demand, has pushed margins for basic chemicals down to extremely low levels. Reuters described the Singapore closure in direct terms: it is part of a wider global trend of petrochemical capacity cuts amid industry losses.
What does that mean? It means Asia’s petrochemical capacity rationalization is accelerating.
In the past, the market often assumed that large plants would not shut easily. Now, even global majors are taking the lead in closures. For non-integrated, high-cost and low-efficiency smaller units, the pressure will only become stronger. The assets most likely to survive will be those with low-cost feedstock routes, large integrated bases close to demand, or downstream chains that can absorb volatility.
For Chinese Producers, the Window Is Opening, But the Threshold Is Rising
The exit of high-cost overseas capacity does create export and regional supply opportunities for Chinese producers. But it would be too early to celebrate.
This opportunity cannot be captured by low prices alone.
Buyers in Europe, the United States and mature Asian markets are no longer looking only at price. They also care about carbon footprint, compliance documents, long-term delivery stability and supply-chain resilience. If companies still rely only on old-style price competition, the road ahead will become narrower.
Only producers that combine scale advantages with higher-end products, differentiation and stable supply can truly benefit from the global capacity reshuffle.
The Old Cycle Is Being Compressed, and a New One Is Being Forced Out
ExxonMobil’s shutdown may look, on the surface, like one company’s operational adjustment. In reality, it reflects how the global petrochemical industry is trying to find a new balance through capacity exits. This is not the end of the story. It is the beginning of a new round of restructuring.
For buyers, future supply chains may become more concentrated, making it more important to lock in reliable resources ahead of time. For producers, the competition is no longer about who has the biggest capacity. It is about whose asset quality is stronger and whose supply chain can withstand pressure.
The petrochemical winter has not yet reached its bottom. But every time a giant shuts a plant, it pushes the industry toward a more efficient and more concentrated future.
2026-10-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
INEOS Closes US Polystrene Plant: 400K Tons of PD in the US Can't Hold On
-
Lotte Merges with HD Hyundai: Can Korea’s Petrochemical First Case Trigger True Restructuring?
-
Evonik Cuts 3,200 Jobs: Europe’s Chemical Winter Is Not Over
-
As Middle East Supply Faces Disruptions, SABIC's 1.8 Million Mt/Year Methanol New Project Secures Saudi Feedstock Quota
-
South Korea Moves Urgently to Control Petrochemical Feedstock Hoarding as Supply Chain Risk Escalates to the National Security Level
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
-
Hormuz Crisis Pushes Up Urea Prices as Yara’s Quarterly EBITDA Jumps 39%
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
Recommend Reading
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
Syensqo Launches AI-Developed Coffee Peptide for Scalp Care
-
Henkel to Acquire Olaplex in $1.4 Billion Deal
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
Due to Supply Chain Disruptions, A Major MDI/TDI Facility in the Middle East has Suddenly Shut Down!
-
Business Society September 16, 2026 Aniline Trend Analysis: Volatile but Bullish
-
October Palm Oil Market Fluctuates and Falls
-
Business Society’s Urea Trend Analysis for September 16, 2026: Volatile with a Slight Bullish Bias
-
Cyclohexane Market Prices Mainly Stable in China
-
Fundamentals Weak, TDI Market in China Declines in October
- Hot Searches
- dimethyl carbonate price
- rad 150 for sale
- pp polypropylene resin price asia 2025 english
- carnauba wax supplier
- lithium hydrozide
- sodium lignosulfonate price
- itpp for sale
- benzoic acid vs sodium benzoate
- sodium cholride
- reta peptide buy
- azithromycin dihydrate api market price 2026
- retta weight loss buy